High-resolution genome-wide array comparative genomic hybridization in splenic marginal zone B-cell lymphoma.

Splenic marginal zone B-cell lymphoma is characterized by high genetic heterogeneity, and hepatitis C virus infection seems to be involved in a subset of patients. The aims of the analysis were to identify potential genetic alterations related to hepatitis C virus status, IgV(H) gene mutational status, and prognostic categories identified in a multicenter study (Blood 2006;107:4643). Genome-wide array comparative genomic hybridization at a 100-kilobase (kb) resolution was performed in 34 patients with splenic marginal zone B-cell lymphoma, 12 of whom were hepatitis C virus positive. Array-comparative genomic hybridization experiments revealed no copy number alterations in 10 patients (4 were hepatitis C virus positive). A median of 5.6 and 3.8 copy number alterations were detected in hepatitis C virus-positive and in hepatitis C virus-negative patients, respectively. The most frequent copy number alterations involved chromosomes 7 and 17 (21% and 24%, respectively). Except for Xp gain (P = .01), no differences in common alterations were found between hepatitis C virus-positive and hepatitis C virus-negative cases. Unmutated status of the IgV(H) gene was related to del(7q) (P = .04) and dup(12q) (P = .03). The high-risk group identified according to the new splenic marginal zone B-cell lymphoma prognostic score was associated with del(7q) (P = .01) and del(17p) (P = .02). Hepatitis C virus-positive splenic marginal zone B-cell lymphoma patients have no specific chromosome alterations. Patients with poor prognosis are characterized by distinctive imbalances.

[1]  G. Salles,et al.  Cytogenetic analysis delineates a spectrum of chromosomal changes that can distinguish non-MALT marginal zone B-cell lymphomas among mature B-cell entities: a description of 103 cases , 2005, Leukemia.

[2]  X. Mariette,et al.  Regression of splenic lymphoma with villous lymphocytes after treatment of hepatitis C virus infection. , 2002, The New England journal of medicine.

[3]  C. Andersen,et al.  Recurrent genomic imbalances in B-cell splenic marginal-zone lymphoma revealed by comparative genomic hybridization. , 2005, Cancer genetics and cytogenetics.

[4]  J. Climent,et al.  Malignant Lymphomas Splenic marginal zone B-cell lymphomas : two cytogenetic subtypes , one with gain of 3 q and the other with loss of 7 q , 2022 .

[5]  H. Fiegler,et al.  Guidelines for molecular karyotyping in constitutional genetic diagnosis , 2007, European Journal of Human Genetics.

[6]  Juan F. García,et al.  Comparative genome profiling across subtypes of low-grade B-cell lymphoma identifies type-specific and common aberrations that target genes with a role in B-cell neoplasia , 2008, Haematologica.

[7]  K. Reddy,et al.  Chronic lymphocytic leukaemia profiled for prognosis using a fluorescence in situ hybridisation panel , 2006, British journal of haematology.

[8]  L. Cro,et al.  Poor prognosis in non‐villous splenic marginal zone cell lymphoma is associated with p53 mutations , 1997, British journal of haematology.

[9]  E. Kelemen.  Specific thrombopoietin cloned and sequenced--with personal retrospect and clinical prospects. , 1995, Leukemia.

[10]  A. Salar,et al.  Splenic marginal zone lymphoma proposals for a revision of diagnostic, staging and therapeutic criteria , 2008, Leukemia.

[11]  E. Campo,et al.  Analysis of the IgV(H) somatic mutations in splenic marginal zone lymphoma defines a group of unmutated cases with frequent 7q deletion and adverse clinical course. , 2002, Blood.

[12]  Bart De Moor,et al.  Molecular Karyotyping: Array CGH Quality Criteria for Constitutional Genetic Diagnosis , 2005, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[13]  C. Pascutto,et al.  Splenic and nodal marginal zone lymphomas are indolent disorders at high hepatitis C virus seroprevalence with distinct presenting features but similar morphologic and phenotypic profiles , 2004, Cancer.

[14]  Patrice Duroux,et al.  IMGT/LIGM-DB, the IMGT® comprehensive database of immunoglobulin and T cell receptor nucleotide sequences , 2005, Nucleic Acids Res..

[15]  C. Mecucci,et al.  Different genomic imbalances in low- and high-grade HCV-related lymphomas , 2008, Leukemia.

[16]  E. Campo,et al.  New chromosomal alterations in a series of 23 splenic marginal zone lymphoma patients revealed by Spectral Karyotyping (SKY). , 2008, Leukemia research.

[17]  Raj Chari,et al.  Computational Methods for the Analysis of Array Comparative Genomic Hybridization , 2006 .

[18]  C. Andersen,et al.  A narrow deletion of 7q is common to HCL, and SMZL, but not CLL , 2004, European journal of haematology.

[19]  D. Ledbetter.  Cytogenetic technology--genotype and phenotype. , 2008, New England Journal of Medicine.

[20]  S. Poppema,et al.  Splenic Marginal Zone Lymphomas Presenting with Splenomegaly and Typical Immunophenotype Are Characterized by Allelic Loss in 7q31–32 , 2003, Modern Pathology.

[21]  F. Solé,et al.  Frequent involvement of chromosomes 1, 3, 7 and 8 in splenic marginal zone B‐cell lymphoma , 1997, British journal of haematology.

[22]  D. Oscier,et al.  Splenic marginal zone lymphoma. , 2005, Blood reviews.

[23]  Christian Chena,et al.  Biallelic deletion 13q14.3 in patients with chronic lymphocytic leukemia: cytogenetic, FISH and clinical studies , 2008, European journal of haematology.

[24]  E. Iannitto,et al.  Splenic marginal zone lymphoma: a prognostic model for clinical use. , 2006, Blood.

[25]  C. Croce,et al.  Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[26]  Frank Speleman,et al.  Detection of DNA copy number alterations in cancer by array comparative genomic hybridization , 2007 .

[27]  D. Bartel.  MicroRNAs Genomics, Biogenesis, Mechanism, and Function , 2004, Cell.

[28]  Garand,et al.  Genetic analysis of splenic lymphoma with villous lymphocytes: a Groupe Français d'Hématologie Cellulaire (GFHC) study , 1998, British journal of haematology.

[29]  M. Mateo,et al.  MicroRNA losses in the frequently deleted region of 7q in SMZL , 2007, Leukemia.

[30]  R. Fonseca,et al.  High Resolution Array-Based Analysis in Marginal Zone Lymphomas and Lymphoplasmacytic Lymphomas Identified Disease-Specific Patterns of Chromosome Abnormalities , 2008 .

[31]  B. Nathwani,et al.  Numerical cytogenetic abnormalities of chromosomes 3, 7, and 12 in marginal zone B-cell lymphomas. , 1996, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.

[32]  D. Catovsky,et al.  Cytogenetic studies in splenic lymphoma with villous lymphocytes , 1993, British journal of haematology.

[33]  Chang-Zheng Chen,et al.  MicroRNAs as oncogenes and tumor suppressors. , 2005, The New England journal of medicine.

[34]  J. Cheng,et al.  Identification of miRNAs associated with tumorigenesis of retinoblastoma by miRNA microarray analysis , 2008, Child's Nervous System.

[35]  J. Climent,et al.  Splenic marginal zone B-cell lymphomas: two cytogenetic subtypes, one with gain of 3q and the other with loss of 7q. , 2001, Haematologica.

[36]  Jun Yokota,et al.  Molecular processes of chromosome 9p21 deletions in human cancers , 2003, Oncogene.